Herbalife Ltd.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $228.3M | $254.3M | $142.2M | $321.3M | $447.2M | $372.6M | $311.0M | $296.6M |
| Depreciation & Amortization | $121.2M | $121.4M | $113.3M | $115.4M | $107.6M | $100.3M | $97.7M | $100.4M |
| Depreciation | $99.4M | $96.5M | $88.9M | $94.3M | $89.2M | $80.9M | $78.8M | $80.8M |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $44.1M | $50.0M | $48.0M | $44.4M | $54.1M | $51.0M | $38.6M | $35.5M |
| Net Cash from Operating Activities | $333.3M | $285.4M | $357.5M | $352.5M | $460.3M | $628.6M | $457.5M | $648.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $80.4M | $122.0M | $135.0M | $156.4M | $151.4M | $112.0M | $106.1M | $84.0M |
| Business Acquisitions | $25.5M | $0 | $0 | — | — | — | — | — |
| Net Cash from Investing Activities | $-108.7M | $-84.6M | $-134.8M | $-156.2M | $-156.4M | $-123.2M | $-108.0M | $-83.9M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | $0 |
| Stock Repurchases | $8.2M | $8.3M | $11.0M | $146.7M | $1.01B | $923.5M | $16.7M | $750.3M |
| Net Cash from Financing Activities | $-295.5M | $-335.3M | $-148.3M | $-264.7M | $-728.6M | $-320.9M | $-713.0M | $-593.1M |
| Net Change in Cash | $-62.8M | $-157.4M | $79.2M | $-94.1M | $-443.6M | $206.5M | $-367.5M | $-80.5M |
| Free Cash Flow | $252.9M | $163.4M | $222.5M | $196.1M | $308.9M | $516.6M | $351.4M | $564.4M |